Processa Pharmaceuticals Announces Prioritization on Development of Next Generation Chemotherapies
21 févr. 2023 08h30 HE
|
Processa Pharmaceuticals, Inc.
Our Next Generation Chemotherapies (NGCs) are cancer treatments where the metabolism and/or distribution of an FDA-approved drug has been altered to provide potentially safer and more effective...